Projects per year
Search results
-
Active
Australian Autoimmune Encephalitis Consortium Study - improving diagnosis, outcomes, and quality of care for patients with this devastating neurological illness.
Monif, M. (Primary Chief Investigator (PCI)), Wesselingh, R. (Chief Investigator (CI)), Butzkueven, H. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Malpas, C. (Chief Investigator (CI)), Haartsen, J. (Chief Investigator (CI)), Hardy, T. A. (Chief Investigator (CI)), Gillis, D. (Chief Investigator (CI)), Seneviratne, U. (Chief Investigator (CI)), Blum, S. (Chief Investigator (CI)), Nesbitt, C. S. (Chief Investigator (CI)), Heiss, L. (Chief Investigator (CI)), Macdonell, R. A. L. (Chief Investigator (CI)), Mykytowycz, M. (Chief Investigator (CI)), Sanfilippo, P. (Chief Investigator (CI)), D'Souza, W. J. (Associate Investigator (AI)), Kulkarni, J. (Associate Investigator (AI)), Buzzard, K. (Associate Investigator (AI)), O'Brien, T. (Associate Investigator (AI)), Broadley, S. (Associate Investigator (AI)), Taylor, B. V. (Associate Investigator (AI)), MacIntyre, J. (Associate Investigator (AI)), Barton, J. (Associate Investigator (AI)), Swayne, A. (Associate Investigator (AI)), Alpitsis, R. (Associate Investigator (AI)), Harding, I. (Associate Investigator (AI)), Butler, E. (Associate Investigator (AI)), Ramanathan, S. (Associate Investigator (AI)), Giles, A. (Associate Investigator (AI)) & Gadi, M. (Associate Investigator (AI))
1/03/24 → 31/12/27
Project: Research
-
PERSONAL: Personalised Selection of Medication for Newly Diagnosed Adult Epilepsy – the PERSONAL Trial
Kwan, P. (Primary Chief Investigator (PCI)), Chen, Z. (Chief Investigator (CI)), Lannin, N. (Chief Investigator (CI)), Ademi Delaney, Z. (Chief Investigator (CI)), Ge, Z. (Chief Investigator (CI)), Reutens, D. (Chief Investigator (CI)), O'Brien, T. (Chief Investigator (CI)), D'Souza, W. J. (Chief Investigator (CI)), Perucca, P. (Chief Investigator (CI)), Reeder, S. (Chief Investigator (CI)), Nikpour, A. (Associate Investigator (AI)), Wong, C. (Associate Investigator (AI)), Kiley, M. (Associate Investigator (AI)), Saw, J.-L. (Associate Investigator (AI)), Nicolo, J.-P. (Associate Investigator (AI)), Seneviratne, U. (Associate Investigator (AI)), Carney, P. (Associate Investigator (AI)), Jones, D. (Associate Investigator (AI)), Somerville, E. R. (Associate Investigator (AI)) & Stapleton, C. (Associate Investigator (AI))
1/02/23 → 31/01/27
Project: Research
-
Autoimmune Encephalitis - a rare and debilitating neurological illness affecting the Australian population. A study of the Australian Autoimmune Encephalitis Consortium.
Monif, M. (Primary Chief Investigator (PCI)), Butzkueven, H. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Kalincik, T. (Chief Investigator (CI)), Tarlinton, D. (Chief Investigator (CI)), Seneviratne, U. (Chief Investigator (CI)), Kulkarni, J. (Chief Investigator (CI)), Buzzard, K. (Chief Investigator (CI)) & Taylor, B. V. (Chief Investigator (CI))
1/06/20 → 31/05/25
Project: Research
-
Finished
Monash Health Status Epilepticus Registry
Muthusamy, S., Foong, Y. C. & Seneviratne, U.
13/03/23 → 31/03/24
Project: Research
-
An Open-Label, Multicenter, Extension Study To Evaluate The Safety And Efficacy Of Padsevonil As Adjunctive Treatment Of Focal-Onset Seizures In Adult Subjects With Drug-Resistant Epilepsy
Seneviratne, U. (Primary Chief Investigator (PCI))
20/06/19 → 19/06/24
Project: Research
-
An open-label, multicenter, extension study to evaluate the safety and efficacy of Padsevonil as adjunctive treatment of focal-onset seizures in adult subjects with drug-resistant epilepsy.
O'Brien, T. (Primary Chief Investigator (PCI)), Perucca, P. (Chief Investigator (CI)), D'Souza, W. J. (Chief Investigator (CI)), Berkovic, S. F. (Chief Investigator (CI)), Wijayath, M. (Chief Investigator (CI)), Carney, P. (Chief Investigator (CI)), Seneviratne, U. (Chief Investigator (CI)), Reutens, D. C. (Chief Investigator (CI)), Zentner, C. (Chief Investigator (CI)), Frasca, J. (Chief Investigator (CI)) & Nikpour, A. (Chief Investigator (CI))
4/06/19 → 31/12/21
Project: Research
-
A Randomized, Double-Blind, Placebo-Controlled, Dose Finding Study To Evaluate The Efficacy And Safety of Padsevonil As Adjunctive Treatment Of Focal-Onset Seizures In Adult Subjects With Drug-Resistant Epilepsy
Seneviratne, U. (Primary Chief Investigator (PCI))
1/02/19 → 1/02/24
Project: Research
-
ARISE: pAdsevonil in drug-ResIStant Epilepsy. A randomized, double-blind, placebo-controlled, dose finding study to evaluate the efficacy and safety of Padsevonil as adjunctive treatment of focal-onset seizures in adult subjects with drug resistant epilepsy.
O'Brien, T. (Primary Chief Investigator (PCI)), Kwan, P. (Chief Investigator (CI)), D'Souza, W. J. (Chief Investigator (CI)), Berkovic, S. F. (Chief Investigator (CI)), Wijayath, M. (Chief Investigator (CI)), Carney, P. (Chief Investigator (CI)), Lawn, N. D. (Chief Investigator (CI)), Seneviratne, U. (Chief Investigator (CI)), Reutens, D. C. (Chief Investigator (CI)), Zentner, C. (Chief Investigator (CI)) & Frasca, J. (Chief Investigator (CI))
11/12/18 → 11/12/19
Project: Research